HS Icon Vaccines, human use

300220 (Harmonized System 1992 for 6-digit)

Overview This page contains the latest trade data of Vaccines, human use. In 2020, Vaccines, human use were the world's 69th most traded product, with a total trade of $32.6B. Between 2019 and 2020 the exports of Vaccines, human use grew by 1.11%, from $32.3B to $32.6B. Trade in Vaccines, human use represent 0.19% of total world trade.

Vaccines, human use are a part of Vaccines, blood, antisera, toxins and cultures.

Exports In 2020 the top exporters of Vaccines, human use  were Belgium ($11.4B), Ireland ($6.07B), France ($4.41B), United States ($2.03B), and Italy ($1.7B).

Imports In 2020 the top importers of Vaccines, human use were Belgium ($7.58B), United States ($7.46B), Germany ($1.69B), China ($1.41B), and United Kingdom ($1.22B).

Tariffs In 2018 the average tariff for Vaccines, human use was 0.86%, making it the 6418th lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Vaccines, human use are French Polynesia (13.4%), Democratic Republic of the Congo (10%), India (8.18%), and Aruba (6%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Algeria (0%), Egypt (0%), and Ethiopia (0%).

Ranking Vaccines, human use ranks 1174th in the Product Complexity Index (PCI).

Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Vaccines, human use. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Historical Data

#permalink to section

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2020): Belgium, $11.4B

Top Destination (2020): Belgium, $7.58B

Vaccines, human use are the world's 69th most traded product.

In 2020, the top exporters of Vaccines, human use were Belgium ($11.4B), Ireland ($6.07B), France ($4.41B), United States ($2.03B), and Italy ($1.7B).

In 2020, the top importers of Vaccines, human use were Belgium ($7.58B), United States ($7.46B), Germany ($1.69B), China ($1.41B), and United Kingdom ($1.22B).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2019 -  2020): Belgium, $2.53B

Top Destination Growth (2019 - 2020): Belgium, $1.11B

Between 2019 and 2020, the exports of Vaccines, human use grew the fastest in Belgium ($2.53B), Italy ($632M), Netherlands ($223M), China ($179M), and Poland ($92.4M).

Between 2019 and 2020, the fastest growing importers of Vaccines, human use were Belgium ($1.11B), China ($549M), Spain ($368M), Poland ($218M), and Vietnam ($134M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

Value

This chart shows the evolution of the market concentration of exports of Vaccines, human use.

In 2020,  market concentration measured using Shannon Entropy, was 3.18. This means that most of the exports of Vaccines, human use are explained by 9 countries.

Explore Visualizations

TOP NET EXPORTER (2020): Ireland, $5.72B

TOP NET IMPORTER (2020): United States, $5.43B

This map shows which countries export or import more of Vaccines, human use. Each country is colored based on the difference in exports and imports of Vaccines, human use during 2020.

In 2020, the countries that had a largest trade value in exports than in imports of Vaccines, human use were Ireland ($5.72B), Belgium ($3.86B), France ($3.7B), Italy ($1.23B), and India ($410M).

In 2020, the countries that had a largest trade value in imports than in exports of Vaccines, human use were United States ($5.43B), China ($1.12B), Germany ($1.08B), Brazil ($695M), and Spain ($462M).

Country Comparison

#permalink to section
Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Vaccines, human use.
It is possible to select the main countries that export or import Vaccines, human use in the world, or by continent, as well as select the measure of interest.

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.